Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy and longer-term breast cancer patient outcomes (Alliance Z1031)
- Citation:
- Clin Cancer Res vol 28 (15) 3287-95
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 11
- Parents:
- 3544
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233329, UG1CA233339; CPRIT, RP180712, BCRF-158, R01 CA095614, 2P50CA186784, Established Investigator Award (RR140027)
- Corr. Author:
- Authors:
- Vera J. Suman Lili Du Tanya Hoskin Meenakshi Anurag Cynthia Ma Isabelle Bedrosian Kelly K. Hunt Matthew J. Ellis W. Fraser Symmans
- Networks:
- LAPS-MO011, LAPS-TX035, TX041
- Study
- Alliance-A151701
- Multiple Studies, or Legacy Studies in Alliance Study:
- ACOSOG-Z1031
- Phases:
- N/A, 3
- Keywords: